Chan, Samuel
Hawley, Carmel M.
Pascoe, Elaine M.
Cao, Christopher
Campbell, Katrina L.
Campbell, Scott B.
Francis, Ross S.
Hale, Rachael
Isbel, Nicole M.
Morrison, Mark
Johnson, David W.
Funding for this research was provided by:
Metro South Health
Article History
Received: 13 January 2021
Accepted: 2 January 2023
First Online: 16 January 2023
Declarations
:
: This study has received ethics approval and consent to participate by the Metro South Human Research and Ethics Committee (HREC/2020/QMS/51887).
: The authors of this paper give consent for this study protocol to be published. We are also willing to provide a model consent form if required.
: Samuel Chan is supported by the Australian National Health and Medical Research Council (NHMRC) Postgraduate Scholarship, the Microba recipient grant, the Metro South Research Support Scheme and the Royal Australasian College of Physicians NHMRC Jacquot Research Excellence top-up award. Furthermore, Dr. Chan is a current recipient of the 2018 Sir Gustav Nossal NHMRC Postgraduate Scholarship award. Carmel Hawley is the recipient of research grants paid to her institution from Baxter Healthcare and Fresenius Medical Care and from Otsuka, Janssen and GlaxoSmithKline for trial steering committee activities, paid to her institution. David Johnson has received consultancy fees, research grants, speaker’s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care. He has received consultancy fees from AstraZeneca, Bayey and AWAK, speaker’s honoraria from Ono, and travel sponsorships from Amgen. He is a current recipient of an Australian NHMRC Practitioner Fellowship. Nicole Isbel has received consultancy fees and speaker’s honoraria from Alexion Pharmaceuticals, Novo Nordisk and Amgen. Katrina Campbell has received consultancy fees from Nestle Health Sciences and speaker’s honoraria from Amgen. The remaining authors declare that they have no competing interests.